Velsera
Velsera is a biotech company in Boston, United States, founded in 2023. It has 1 recorded funding round, most recently a Private Equity in January 2023.
Solutions for Clinical Genomics Implementation, Reporting, and Multimodal Data Analysis
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2023
- Business Model
- B2B
- Website
- velsera.com
- Last Round
- Private EquityJan 2023
- Rounds
- 1
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Velsera provides advanced software and expert services to accelerate the discovery, development, and delivery of precision medicine globally. It partners with life science and clinical diagnostic organizations developing drugs and diagnostics for genetic diseases. Its capabilities include data harmonization, bioinformatics workflows, and clinical interpretation and reporting for diagnostic testing.
Summary
It lists 51–200 employees. Its most recent funding was a Private Equity round in Jan 2023. Investors include Summa Group.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/velsera"><img src="https://indexed.vc/api/badge/company/velsera" alt="Velsera on Indexed.vc" width="260" height="76" /></a>